RMD Media Release Archive

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008



16. December 2011
New Roche screening test for abacavir hypersensitivity available in Europe
HLA-B*5701 screening provides physicians with a means to avoid prescribing drugs to patients at high risk of allergic reactions to a drug called abacavir for the treatment of HIV and AIDS.more
19. September 2011
ATHENA Data Presented at International Papillomavirus Conference Support Use of Roche’s cobas® HPV Test in Primary Screening for Cervical Cancer
Data demonstrates the cobas® HPV Test, with its option of individual HPV 16 and 18 genotyping, provides additional risk stratification for high risk HPV-positive women more
23. August 2011
Companion Diagnostic Test that Identifies Patients With Melanoma Tumor Mutation Available in Europe
cobas BRAF Mutation Test is used to identify patients with melanoma tumors that harbor a genetic mutation which can be treated with Zelboraf (vemurafenib)more
22. July 2011
KRAS Diagnostic Test that assists with personalized treatment of colorectal cancer receives CE Mark
cobas KRAS Mutation Test identifies colorectal cancer patients not likely to respond to anti-EGFR antibody therapiesmore
07. June 2011
Roche and Merck Collaborate to Develop Diagnostic Tests for Merck’s Investigational Cancer Therapies
Merck and Roche today announced that they have entered into a collaboration focused on the application and development of diagnostic assays for use with Merck's investigational cancer therapy portfolio.more
02. June 2011
Roche and Clovis Oncology to co-develop EGFR companion diagnostic
Collaboration focused on personalized treatment of non-small-cell lung cancer more
23. May 2011
Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark
cobas® TaqScreen MPX Test, v2.0 provides real-time results for HIV, HCV and HBV. more
19. May 2011
Roche expands use of novel HIV test
Test with enhanced reliability for monitoring HIV patients now CE markedmore
06. May 2011
Roche submits application for clearance of Chlamydia and Gonorrhoeae test
Test detects and expands menu on the recently approved cobas 4800 instrument more
31. March 2011
Roche's test for Cytomegalovirus is approved in Europe
Roche announced today that its Cytomegalovirus (CMV) test is now commercially available in Europe. CMV viral load testing helps physicians manage immunocompromised patients at risk of CMV disease. more
31. March 2011
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
New test standardizes CMV testing for both solid organ and hematopoietic stem cell transplant recipients more
24. February 2011
Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer
ATHENA study shows the cobas HPV Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancermore
04. February 2011
First Duplex Test for Parvovirus B19 and Hepatitis A Virus Now Available in the US
Roche announced today that the cobas® TaqScreen DPX Test for use on the cobas s 201 system is now available in the US. It is the first commercial test to quantify ...more
18. January 2011
Roche Molecular Systems launches redesigned Website
Roche Molecular Systems announced the launch of a new Website that’s designed with users’ needs in mind. Work on the site began in the fall of 2009, with RMD conducting ...more